Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer

Minerva Urol Nefrol. 2010 Jun;62(2):129-32.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • BCG Vaccine / therapeutic use
  • Humans
  • Immunologic Factors / therapeutic use*
  • Neoplasm Invasiveness
  • Treatment Failure
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / pathology

Substances

  • Adjuvants, Immunologic
  • BCG Vaccine
  • Immunologic Factors